Minimal residual disease monitoring by Ig/TCR rearrangement predicts post-transplant relapse and survival in adult patients with acute lymphoblastic leukemia

Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.